Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Clin Interv Aging ; 13: 641-649, 2018.
Article in English | MEDLINE | ID: mdl-29713148

ABSTRACT

PURPOSE: Inflammatory factors play a critical role in contrast-induced acute kidney injury (CI-AKI). Prealbumin, a nutritional and inflammatory indicator, is a well-established predictor of short- and long-term outcomes in numerous clinical conditions. The current study investigated the association of pre-procedural prealbumin levels with CI-AKI and long-term outcomes in geriatric patients after elective percutaneous coronary intervention (PCI). PATIENTS AND METHODS: A total of 558 patients aged≥75 years, who underwent elective PCI between January 2012 and December 2015, were selected for the current study. Pre-procedural prealbumin levels were measured before PCI. Multivariable logistic regression and Cox proportional hazard regression analyses were performed to identify the independent risk factors for CI-AKI and long-term mortality. RESULTS: Out of 558 patients, 54 developed CI-AKI. The optimal cutoff value of prealbumin for detecting CI-AKI was 185.5 mg/L with 62.7% sensitivity and 70.4% specificity based on the receiver operating characteristic analysis (C-statistic=0.710; 95% confidence interval [CI] 0.673-0.751). Multivariable analysis demonstrated that prealbumin≤185.5 mg/L was significantly associated with CI-AKI (odds ratio [OR] 0.397; 95% CI 0.195-0.808; P=0.011). Cox regression analysis demonstrated that prealbumin≤185.5 mg/L was associated with long-term mortality (adjusted hazard ratio [HR] 0.525; 95% CI 0.289-0.952; P=0.034) during the follow-up. CONCLUSION: Pre-procedural levels of prealbumin were independently associated with an increased risk of CI-AKI and long-term mortality in elderly patients undergoing elective PCI.


Subject(s)
Acute Kidney Injury , Contrast Media/adverse effects , Natriuretic Peptide, Brain/analysis , Peptide Fragments/analysis , Percutaneous Coronary Intervention , Postoperative Complications , Acute Kidney Injury/chemically induced , Acute Kidney Injury/diagnosis , Acute Kidney Injury/epidemiology , Acute Kidney Injury/prevention & control , Aged , Elective Surgical Procedures , Female , Humans , Long Term Adverse Effects/chemically induced , Long Term Adverse Effects/epidemiology , Long Term Adverse Effects/prevention & control , Male , Percutaneous Coronary Intervention/adverse effects , Percutaneous Coronary Intervention/methods , Postoperative Complications/diagnosis , Postoperative Complications/epidemiology , Postoperative Complications/prevention & control , Prealbumin/analysis , Predictive Value of Tests , Reproducibility of Results , Risk Factors
2.
Sheng Wu Gong Cheng Xue Bao ; 23(3): 403-8, 2007 May.
Article in Chinese | MEDLINE | ID: mdl-17577983

ABSTRACT

In this study, a 15-mer phage display peptide library was employed to pan against human rotavirus immobilized on solid phase. 4 different peptides were selected and could bind with rotavirus particles specifically. Plaque reduction neutralization test and MTT analysis results indicated that 3 of the peptides can inhibit rotavirus infecting in vitro. A peptide which sequence is QSNPIHIITNTRNHP showed the best efficiency--93% neutralization infectivity. Two other peptides, A and B, showed 40% and 50% neutralization infectivity respectively. Amino sequence analysis results indicate the 3 peptides containing 2 conserved motifs: SNPIHII and NIP. No putative trypsin hydrolysis site was found in C peptide, however, 4 and 3 potential sites were found in A and B peptides respectively. Using trypsin inhibitor, both A and B peptides showed the similar antiviral effect as that of C peptide. It suggests that the intactness of the 2 conserved motifs play an important role in counteracting virus infection. According to the results of this study, peptide C is hopeful to be exploited as an antiviral peptide drug.


Subject(s)
Antiviral Agents/pharmacology , Peptide Library , Peptides/pharmacology , Rotavirus/drug effects , Amino Acid Sequence , Animals , Antiviral Agents/isolation & purification , Cell Line , Cell Survival/drug effects , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Humans , Molecular Sequence Data , Neutralization Tests , Peptides/chemistry , Peptides/immunology , Protein Binding , Rotavirus/growth & development , Rotavirus/immunology , Sequence Analysis, Protein , Viral Plaque Assay
SELECTION OF CITATIONS
SEARCH DETAIL
...